Announcements Trials

Browse Landscape

Phase

Status

Completed 9 Terminated 5 Unknown 1 Recruiting 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Colorectal Neoplasms 2 Stomach Neoplasms 1 Neoplasm Metastasis 1 Metastatic Colorectal Adenocarcinoma 1 Advanced Gastric or EGJ Cancer 1

Interventions

pembrolizumab 34 Specimen Handling 18 Paclitaxel 16 Magnetic Resonance Spectroscopy 15 Carboplatin 14 Biopsy 14 Nivolumab 13 Ipilimumab 12 Gemcitabine 10 Irinotecan 9 Radiosurgery 8 atezolizumab 7 abemaciclib 7 Radiation 7 Pemetrexed 7 Cisplatin 7 Capecitabine 7 130-nm albumin-bound paclitaxel 7 trastuzumab deruxtecan 6 olaparib 6 durvalumab 6 avelumab 6 Docetaxel 6 osimertinib 5 adagrasib 5 Trastuzumab 5 Fulvestrant 5 Cetuximab 5 Albumin-Bound Paclitaxel 5 palbociclib 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × Neoplasm Metastasis × IFL protocol × Clear all

NCT03806309 2025-07-25

TEDOPAM

GERCOR - Multidisciplinary Oncology Cooperative Group

Phase 2 Active not recruiting

Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡